Repligen Corp.
(NASDAQ : RGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.40%144.510.7%$896.81m
PFEPfizer Inc. 0.51%37.270.9%$768.11m
MRKMerck & Co., Inc. 0.73%78.640.7%$630.12m
BMYBristol-Myers Squibb Co. 0.53%60.351.0%$625.81m
ABBVAbbVie, Inc. 2.03%84.571.9%$603.78m
LLYEli Lilly & Co. 0.46%141.961.1%$486.01m
AZNAstraZeneca Plc 0.59%51.881.2%$203.40m
NVSNovartis AG 0.27%84.370.2%$142.41m
GSKGlaxoSmithKline Plc -0.81%35.070.2%$137.80m
NVONovo Nordisk A/S -0.44%70.540.1%$69.63m
RPRXRoyalty Pharma Plc -0.05%38.980.2%$63.62m
RGENRepligen Corp. 1.83%174.917.1%$63.58m
SNYSanofi -0.25%49.050.2%$49.86m
AMAGAMAG Pharmaceuticals, Inc. 0.22%13.6622.1%$45.13m
PRAXPraxis Precision Medicines, Inc. 4.21%31.180.0%$42.16m

Company Profile

Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The firm serves through the following product lines: Chromatography; Filtration; and OEM Products (Proteins). The Chromatography product line includes a number of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The OEM products are represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.